Details Provides immediate access to a $600 million segment of the US aesthetic market via Thermi’s sales infrastructure Expands and complements Sinclair’s portfolio…
This Document is important If you are in doubt as to the action to be taken, please consult an appropriately authorised independent financial…
Details London, 30 March 2017 Sinclair Pharma plc (SPH.L), (“Sinclair” or the “Company”) the international aesthetics company, announces that 1,570,510 new ordinary shares of 1p…
Details London, 17 January 2017 Sinclair Pharma plc (AIM:SPH.L) (“Sinclair” or the “Group”), the international aesthetics company, announces an unaudited trading update for…
Details London, 05 January 2017 Sinclair Pharma plc (SPH.L), (“Sinclair”) the international Aesthetics company, will be publishing a trading update for the year…
Details Highlights Reported revenues show significant growth reflecting strong in market sales and planned de-stocking in prior six month period. Group revenues increased…
At Sinclair we strive to provide the highest standards of training and ongoing support, working in partnership with our physician customers to deliver patients unparalleled clinical results and industry leading safety standards.